| Mr Donald Eugene Atwill, RPH | |
|
601 E Iron Ave, Salina, KS 67401-3035 | |
| (785) 827-4455 | |
| (785) 827-5847 |
| Full Name | Mr Donald Eugene Atwill |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 601 E Iron Ave, Salina, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306191283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10087 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Donald Eugene Atwill, RPH 601 E Iron Ave, Salina, KS 67401-3035 Ph: (785) 827-4455 | Mr Donald Eugene Atwill, RPH 601 E Iron Ave, Salina, KS 67401-3035 Ph: (785) 827-4455 |
News Archive
Radboud University historians and ageing researchers from Leiden University Medical Center (LUMC) will be receiving a grant of over 800,000 euros for research into the influence of 'the family' on child mortality, fertility and life expectancy over the last two hundred years.
Cancer research at the University of Warwick has received a boost. The University's Cancer Research Centre has been given £8.5k to spend on its research to improve detection, treatments and patient care using the expertise of the University's Warwick Medical School and its partners.
The African Agriculture Fund (AAF) announced Monday that it has designated $135 million for expanded food production, agricultural processing and distribution, especially for small holder farms, PANA/Afrique en ligne reports.
A study by Mark Hall, J.D., professor of law and public health sciences at Wake Forest University Baptist Medical Centre, is suggesting that conventional wisdom could be wrong in that primary care doctors who coordinate the care of their patients by specialists may actually have lower liability risk than primary care doctors who do not attempt care coordination.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company's Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT).
› Verified 9 days ago
Jerry Franklin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 809 Elmhurst Blvd, Suite A, Salina, KS 67401 Phone: 785-914-5491 | |
Carleigh Cozad, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 S 9th St, Salina, KS 67401 Phone: 785-825-4449 | |
Thomas Robert Katafiasz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Broadway Blvd, Salina, KS 67401 Phone: 785-825-2248 Fax: 785-825-0455 | |
Vinh Duc Ha, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Santa Fe Ave Ste 1121a, Salina, KS 67401 Phone: 785-452-7531 | |
James Cram, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 650 Rockview Rd, Salina, KS 67401 Phone: 785-825-6014 Fax: 877-297-4979 | |
Erin Conner-desilvey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2919 Market Pl, Salina, KS 67401 Phone: 785-823-7641 Fax: 785-823-7377 | |
Dr. Linda Y. Radke, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Santa Fe Ave, Salina, KS 67401 Phone: 785-452-7705 Fax: 785-452-6945 |